FIELD: pharmacology.
SUBSTANCE: application of sodium-, calcium-, ironpolagalacturonate of the formula (I), where Met1=Na; Met2=SaII, FeII; n=3, m=25, as a hepatoprotective agent.
EFFECT: claimed compound based on the pectin biopolymer not only reduces the functional and structural damage of the liver in toxic hepatitis, but normalizes metabolism impaired as a result of toxic damage by carbon tetrachloride: protein, glucose and cholesterol are raised to the level of physiological norm.
1 tbl
Title | Year | Author | Number |
---|---|---|---|
PHARMACOLOGICAL COMPOSITION FOR INCREASING BODY ADAPTABILITY UNDER EXERCISE CONDITIONS | 2014 |
|
RU2564949C1 |
HEPATOPROTECTOR PREPARATION FOR PROPHYLAXIS AND CORRECTION OF TOXIC HEPATIC LESIONS | 2001 |
|
RU2189817C1 |
PHARMACOLOGICAL COMPOSITION BASED ON WATER-SOLUBLE POLYMETAL COMPLEXES OF POLYGALACTURONIC ACID, STIMULATING HEMATOPOIESIS PROCESS | 2019 |
|
RU2704033C1 |
APPLICATION OF Thr-Lys-Pro-Arg-Pro-Gly-Pro PEPTIDE (SELANK) FOR TOXIC HEPATITIS PREVENTION AND TREATMENT | 2017 |
|
RU2640133C1 |
MEDICATION POSSESSING HEPATOPROTECTIVE ACTION | 2009 |
|
RU2405562C1 |
HEPATOPROTECTING AGENT | 1996 |
|
RU2156130C1 |
ALGAE HEPATOPROTECTIVE AGENT | 2016 |
|
RU2616253C1 |
METHOD OF PREPARING MEDICINAL FORM OF ISONIAZIDE SHOWING DECREASED HEPATOTOXICITY | 1999 |
|
RU2153878C1 |
ANTIOXIDANT AND MEMBRANE STABILISING AGENT | 2012 |
|
RU2540466C2 |
METHOD OF LIVER PROTECTION FROM XENOBIOTICS IN EXPERIMENT | 2000 |
|
RU2195936C2 |
Authors
Dates
2017-11-15—Published
2017-02-27—Filed